...
首页> 外文期刊>Biotechnology Progress >Production of Recombinant Adeno-Associated Viral Vectors Using a Baculovirus/Insect Cell Suspension Culture System:From Shake Flasks to a 20-L Bioreactor
【24h】

Production of Recombinant Adeno-Associated Viral Vectors Using a Baculovirus/Insect Cell Suspension Culture System:From Shake Flasks to a 20-L Bioreactor

机译:使用杆状病毒/昆虫细胞悬浮培养系统生产重组腺相关病毒载体:从摇瓶到20升生物反应器

获取原文
获取原文并翻译 | 示例
           

摘要

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell system at various scales is presented.Shake flask studies were conducted to assess conditions to be used in bioreactors.Two insect cell lines,Trichoplusia ni (H5) and Spodoptera frugiperda (Sf9),were compared for their ability to produce rAAV-2 after infection with recombinant baculoviruses coding for the essential components of the vector.The effect of varying the ratio between individual baculoviruses and the effect of the overall multiplicity of infection (MOD,as well as the cell density at infection,were also examined.Infectious rAAV-2 particles were proportionally produced when increasing the individual MOI of BacRep virus up to 1.6.When equal amounts of each virus were used,a leveling effect occurred beyond an overall MOI of 5 and a maximum titer was obtained.Increasing the cell density at infection resulted in higher yields when infecting the cells in fresh medium;however,for the production of bioactive particles,an optimal peak cell density of approx1 x 10~6 cells/mL was observed without medium exchange.Infection in 3- and 20-L bioreactors was done at an overall MOI of 5 with a ratio of the three baculoviruses equal to 1:1:1.Under these conditions and infecting the cells in fresh medium,a total of approx2.2 x 10~(12) infectious viral particles (bioactive particles) or 2.6 x 10~(15) viral particles were produced in a 3-L bioreactor.Without replacing the medium at infection,similar titers were produced in 20 L.Our data demonstrates the feasibility of rAAV-2 production by BEVS at various scales in bioreactors and indicates that further optimization is required for production at high cell densities.
机译:提出了使用杆状病毒/昆虫细胞系统以不同规模生产重组腺相关病毒载体的方法。进行了摇瓶研究以评估生物反应器中使用的条件。两种昆虫细胞系Trichoplusia ni(H5)和Spodoptera frugiperda(Sf9) ),比较了它们被编码载体基本成分的重组杆状病毒感染后产生rAAV-2的能力。改变各个杆状病毒之间的比例的影响以及感染的总体多重性(MOD和当将BacRep病毒的单个MOI增加到1.6时,会成比例地产生感染性rAAV-2颗粒。当使用每种病毒的等量剂量时,超过5和5的总MOI会产生流平效果在新鲜培养基中感染细胞时,增加感染时的细胞密度会导致更高的产量;但是,对于生产在不进行培养基交换的情况下,观察到最佳的峰值细胞密度约为1 x 10〜6个细胞/ mL。在3和20 L生物反应器中进行感染,总MOI为5,三种杆状病毒的比率等于在这些条件下,并在新鲜培养基中感染细胞,总共产生了约2.2 x 10〜(12)个感染性病毒颗粒(生物活性颗粒)或2.6 x 10〜(15)个病毒颗粒。 3-L生物反应器。无需在感染时更换培养基,即可在20 L中产生相似的滴度。我们的数据证明了BEVS在生物反应器中以不同规模生产rAAV-2的可行性,并表明在高细胞密度下生产需要进一步优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号